The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis,*

被引:1
|
作者
Rosenfeld, Margaret [1 ,2 ]
Cromwell, Elizabeth A. [3 ]
Schechter, Michael S. [4 ]
Ren, Clement [5 ]
Flume, Patrick A. [6 ]
Szczesniak, Rhonda D. [7 ]
Morgan, Wayne J. [8 ]
Jain, Raksha [9 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Cyst Fibrosis Fdn, Patient Registry Res, Bethesda, MD 20814 USA
[4] Viriginia Commonwealth Univ, Div Pulm & Sleep Med, Childrens Hosp Richmond, Richmond, VA USA
[5] Childrens Hosp Philadelphia, Div Pulm & Sleep Med, Philadelphia, PA USA
[6] Med Univ South Carolina, Div Pulm Crit Care Allergy & Sleep Med, Charleston, SC USA
[7] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA
[8] Univ Arizona, Pediat Pulm & Sleep Med, Tucson, AZ USA
[9] Univ Texas Southwestern, Internal Med, Dallas, TX USA
关键词
Cystic fibrosis; Respiratory function tests; Forced expiratory volume; LUNG-FUNCTION; FIBROSIS;
D O I
10.1016/j.jcf.2024.03.013
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: The American Thoracic Society recommended switching to race-neutral spirometry reference equations, as race is a social construct and to avoid normalizing disparities in lung function due to structural racism. Understanding the impact of the race-neutral equations on percent predicted forced expiratory volume in one second (ppFEV1) in people with cystic fibrosis (PwCF) will help prepare patients and providers to interpret pulmonary function test results. Objective(s): To quantify the impact of switching from Global Lung Initiative (GLI) 2012 race-specific to GLI 2022 Global race-neutral reference equations on the distribution of ppFEV1 among PwCF of different races. Methods: Cross-sectional analysis of FEV1 among PwCF ages >= 6 years in the 2021 U.S. Cystic Fibrosis Foundation Patient Registry. We describe the absolute difference in ppFEV1 between the two reference equations by reported race and the effect of age and height on this difference. Results: With the switch to GLI Global, ppFEV1 will increase for White (median increase 4.7, (IQR: 3.1; 6.4)) and Asian (2.6 (IQR: 1.6; 3.7)) individuals and decrease for Black individuals (-7.7, (IQR: -10.9; -5.2)). Other race categories will see minimal changes in median ppFEV1. Individuals with higher baseline ppFEV1 and younger age will see a greater change in ppFEV1 (i.e., a greater improvement among White and Asian individuals and a greater decline among Black individuals). Conclusions: Switching from GLI 2012 race-specific reference equations to GLI 2022 Global race-neutral equations will result in larger reductions in ppFEV1 among Black individuals with CF than increases among White and Asian people with CF.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 36 条
  • [21] IMPACT OF DUAL ROTATING INHALED ANTIPSEUDOMONAL ANTIBIOTICS ON FEV1 IN PEDIATRIC AND ADULT CYSTIC FIBROSIS PATIENTS
    Hood, K.
    Novak, K. J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 320 - 320
  • [22] LONGITUDINAL ASSOCIATIONS BETWEEN FEV1 AND HBA1C IN A UK COHORT OF YOUNG PEOPLE WITH CYSTIC FIBROSIS
    Selby, L.
    Rootsey, T.
    Williams, R.
    Ong, K.
    McShane, D.
    THORAX, 2014, 69 : A161 - A161
  • [23] FACTORS ASSOCIATED WITH WEIGHT GAIN AND IMPROVEMENT IN FEV1 IN PEOPLE WITH CYSTIC FIBROSIS ON ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
    Khare, S.
    Harindhanavudhi, T.
    Wang, Q.
    Espinosa, R.
    Griffin, T. B.
    Downs, E. M.
    Dunitz, J. M.
    Moran, A.
    Moheet, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S81 - S81
  • [24] PHYSIOLOGICAL RESPONSE TO EXERCISE IN AN ADULT CYSTIC FIBROSIS POPULATION: INVESTIGATING THE RELATIONSHIP BETWEEN HRR AT ANAEROBIC THRESHOLD AND FEV1% PREDICTED
    Comber, G.
    THORAX, 2015, 70 : A218 - A218
  • [25] Impact of elexacaftor/tezacaftor/ivacaftor combination therapy on lung function in adults with cystic fibrosis: Beyond FEV1
    Wollsching-Strobel, M.
    Dieninghoff, D.
    Emrich, L. F.
    Kroppen, D.
    Majorski, D. S.
    Mathes, T.
    Magnet, F. S.
    Schwarz, S. B.
    Criee, C.
    Windisch, W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [26] Impact of elexacaftor/tezacaftor/ivacaftor combination therapy on body plethysmography in adults with cystic fibrosis: Beyond FEV1
    Wollsching-Strobel, Maximilian
    Dieninghoff, Doris
    Mathes, Tim
    Stanzel, Sarah B.
    Criee, Carl-Peter
    Windisch, Wolfram
    Berger, Melanie P.
    PNEUMON, 2024, 37 (02)
  • [27] UNDERSTANDING LONGITUDINAL CHANGES IN %FEV1 VARIABILITY AND ITS ROLE AS AN INDICATOR OF CARE QUALITY AMONG ADULTS WITH CYSTIC FIBROSIS
    El-Gheryani, M. S. A.
    Hoo, Z. H.
    Curley, R.
    Wildman, M. J.
    THORAX, 2018, 73 : A85 - A85
  • [28] Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV1 ≤ 50% Predicted
    Ramos, Kathleen J.
    Wai, Travis Hee
    Stephenson, Anne L.
    Sykes, Jenna
    Stanojevic, Sanja
    Rodriguez, Patricia J.
    Bansal, Aasthaa
    Mayer-Hamblett, Nicole
    Goss, Christopher H.
    Kapnadak, Siddhartha G.
    CHEST, 2022, 162 (04) : 757 - 767
  • [29] 'RACE-NEUTRAL' AND 'GLOBAL'? IMPACT OF REFERENCE STANDARDS ON INTERPRETATION OF SPIROMETRY AMONG SOCIO-ECONOMICALLY DEPRIVED, SOUTHERN AFRICAN ADOLESCENTS AND ADULTS
    Calderwood, C. J.
    Banze, D.
    Nhamuave, C.
    Marambire, E. T.
    Larsson, L.
    Minja, T.
    Mfinanga, A.
    Heinrich, N.
    Kranzer, K.
    Ivanova, O.
    Rachow, A.
    Khosa, C.
    THORAX, 2023, 78 (SUPPL_4) : A96 - A96
  • [30] Predicted postoperative FEV1, DLCO and VO2 underestimate the postoperative values after lung resection in patients with symptomatic non-cystic fibrosis bronchiectasis
    Vallilo, Camilla Carlini
    Terra, Ricardo Mingarini
    Albuquerque, Andre
    Salge, Joao Marcos
    Mariani, Alessandro
    Augusto, Marcia
    Suesada, Milena Mako
    Pego-Fernandes, Paulo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46